John Alan Tucker, PhD  |  Medical Chemistry

John Alan Tucker received his PhD in chemistry in the research group of Nobel Laureate Donald Cram in 1987 and his MBA from the Anderson School of Management at UCLA in 2009. His research career spans 25 years performing drug discovery research in metabolic diseases, cancer, HIV infection, anti-bacterials, Alzheimer’s disease and inborn errors of metabolism. John led the medicinal chemistry effort leading to the discovery of the CBLC102 series of anticancer compounds, currently in clinical trials for the treatment of prostate cancer. He has authored 20 peer-reviewed scientific articles, and is listed as an inventor on 19 granted and 12 pending U.S. patents.